The BMW F87 M2 CS is a collector's dream, with values rising fast. Don't miss your chance to own this rare beauty before ...
Then, of course, there’s the M3 CSL, the best version of everyone’s favourite 3 Series. It was notable even in an ...
Welcome back to Choices, where seemingly similar cars are pitted against one another in a battle for your affection.It’s like ...
This video features a quarter-mile drag race between the BMW M3 CSL E46 and the VW Bora VR6. Both cars showcase their ...
A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...
Gift 5 articles to anyone you choose each month when you subscribe. CSL chief financial officer Joy Linton retired on Tuesday. That’s the big Australian biotech trying to change the story. Something ...
CSL has partnered with Dutch biotech VarmX to co-develop VMX-C001, a potential first-in-class treatment to restore blood coagulation in patients on FXa inhibitors. The agreement includes an upfront ...
CSL has moved quickly to spend some of the money freed up by recent cuts, securing an option to buy the phase 3-ready blood clotting specialist VarmX in return for $117 million upfront. Last month, ...
CSL pays $117 million for exclusive option to acquire VarmX VarmX could receive up to $388 million if milestones are met CSL funds VarmX's Phase 3 trial for VMX-C001 Sept 16 (Reuters) - Australia's ...
Plans to spin off CSL Seqirus into listed entity by next June Seeks annualised savings of up to $550 million over three years Lifts dividend and plans A$750 million share buyback Underlying profit up ...
MELBOURNE, Aug. 19, 2025 /PRNewswire/ -- Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant ...
Morningstar says biotech giant CSL is being “undervalued” by the market despite the risk of a 200 per cent tariff on pharmaceuticals flagged by US President Donald Trump in his expanding trade war. If ...